Genmab — April 2023
-
-
US/Middag: LØFT TIL SUNDHED
Det går dog bedre for aktierne i sundhedssektoren, hvor Unitedhealth Group, USA's største sygekasse, løftes 3,2 pct.
Johnson & Johnson vinder også frem med 3,3 pct., da medicinalkæmpen tirsdag aften foreslog et forlig på 8,9 mia. dollar for at afslutte mere end 40.000 søgsmål relateret til koncernens potentielt kræftfremkaldende babypudder.
Trenden er dog bred for branchen med plusser på 2,4-3,1 pct. til Pfizer, Eli Lilly og Merck.
.\˙ MarketWire
-
Godmorgen
-
Kort video: Novo Nordisk ' Zealand Pharma ' Bavarian Nordic ' Genmab
Helge Larsen gennemgår det sidste nye om virksomhederne inden for pharma og biotek ud fra den kvalificerede debat og chat på ProInvestor. https://www.proinvestor.com/boards/111920
-
Always good news when another big pharma starts a trial with your drug; AstraZenca starts A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations (OSTARA) https://clinicaltrials.gov/ct2/show/NCT05801029
-
Nå, så kommer der ikke bud på Genmab inden for nærmeste fremtid. Heller ikke en voldgiftsafgørelse som de har fået et hint om …
-
New Desensitization Strategy: Daratumumab for Highly Sensitized Pediatric Heart Transplant Candidate https://www.sciencedirect.com/science/article/abs/pii/S105324982301361X
-
Use of Daratumumab in Antibody Mediated Rejection in a Heart Transplant Recipient
https://www.jhltonline.org/article/S1053-2498(23)01274-3/fulltext -
We reported that 4 patients with refractory acquired hemophilia A were treated with daratumumab.. All 4 patients achieved varying degrees of remission after daratumumab treatment.. Daratumumab provides a new option for the treatment of refractory acquired hemophilia with good efficacy and safety
. -
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind